MedTech Acquisition Corporation announced that it has issued a promissory note (extension note) in the principal amount of up to $468,821.28, and an unsecured promissory note (working capital note) in the principal amount of up to $1,000,000 for gross proceeds of $1,468,821.28 on December 16, 2022. The transaction included participation from returning investor Medtech Acquisition Sponsor LLC. The Extension Note bears no interest and is repayable in full upon the date of the consummation of an initial business combination.

The Working Capital Note does not bear interest and the principal amount will not be payable if the Company fails to complete its initial business combination within the required time period as set forth in its amendment and restated certificate of incorporation, as amended from time to time. The issuances of the Extension Note and the Working Capital Note were made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.